Piramal Critical Care Revenue and Competitors

Piramal Critical Care (PCC), a business unit of Piramal Pharma, is the third largest producer of inhaled anesthetics and a global player in hospital generics. ‘Save lives with critical care solutions' is much more than a purpose statement to us. We are motivated by our vision of commitment to delivering critical care solutions for patients and healthcare providers across the globe, while achieving sustainable and profitable growth for all the stakeholders. PCC has long track record of assured supply of key products to the critical care market around the world. Our product portfolio includes inhalation anesthetics, Intrathecal Baclofen therapy for spasticity management, Injectable Anti-infectives and Anti-cholinergic . Our products include Sevoflurane, Isoflurane, Gablofen®, MITIGO®, Ceftriaxone for injection, Ampicillin for injection, Ampicillin- sulbactum for injection, Piperacillin-tazobactum for injection, Cefepime for injection, Oxacillin for injection, Linezolid and Glycopyrrolate. PCC has strong manufacturing and process development experience. PCC has fully owned manufacturing plants in Bethlehem, PA and Digwal, India. Customer centricity is the cornerstone of our business. Our core strength lies in our highly qualified global workforce of more than 400 employees across 16 countries.